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Aim: Our objective was to prepare a new nano-sized realgar particle and characterize its anti-
tumor effect on tumor cells.
Methods: Nanoparticles were prepared by coprecipitation and were detected by transmission 
electron microscopy, scanning electron microscopy, energy dispersive spectrometry (EDS), and 
dynamic light scattering. An anti-proliferative effect of realgar nanoparticles on rat glioma (C6) 
cells was determined by the MTT assay. Cell cycle and apoptosis rates were observed by flow 
cytometry. Apoptosis-related gene expression was detected by immunofluorescence staining.
Results: Realgar nanoparticles were successfully prepared. The particles were spherical, with 
an average diameter of approximately 80 nm, and contained arsenic and sulfur elements. Realgar 
nanoparticles inhibited C6 cell proliferation and induced apoptosis in a dose- and time-dependent 
manner. Treatment of C6 cells with realgar nanoparticles significantly increased the proportions 
of cells in S and G2/M phases, decreased the proportion of cells in G0/G1 phase, downregulated 
Bcl-2 expression, and substantially upregulated Bax expression.
Conclusion: Realgar nanoparticles significantly inhibited C6 glioma cell proliferation and 
promoted cell apoptosis by inducing the upregulation of Bax and downregulation of Bcl-2 
expression. Realgar nanoparticles are a promising in vitro anti-cancer strategy and may be 
applicable for human cancer therapy studies.
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Introduction
Glioma is a highly chemoresistant and radioresistant cancer of the brain, with high 
morbidity, high mortality, and extremely poor prognosis. Despite recent advances in 
diagnosis and new treatment options, the median survival time of glioma patients is 
generally less than 2 years.1 Novel and efficient therapeutic strategies are needed for 
this deadly disease.
Realgar has been used as a traditional Chinese medicine for thousands of years. In 
ancient China, realgar (called Xiong-Huang in Chinese) was applied for the treatment 
of carbuncles, scalds and burns, insect bites, abdominal pains, infantile convulsions, 
and psoriasis, among other things.2 Recently, much attention has been given to its 
cytotoxic effect on a variety of cancer cells and its effect on many kinds of leukemia 
such as acute promyelocytic leukemia.3 However, the application of realgar has been 
limited by its insolubility in water. Enhanced solubility and/or preparation as nanopar-
ticles may improve the therapeutic potential of realgar. Although the methods of cryo-
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been reported for many years,3,4 few studies have   considered 
other methods of preparation, and none have evaluated the 
anti-proliferative effect of realgar nanoparticles on solid 
cancers. Here, we developed a novel method for preparing 
realgar nanoparticles for cancer treatment and evaluated their 
inhibitory effect on rat glioma cells.
Materials and methods
Materials
Realgar was obtained from Nanjing Medical Material Co 
(Jiangsu Province, China). High-glucose Dulbecco’s Modi-
fied Eagle’s Medium (DMEM), trypsin, and fetal bovine 
serum were purchased from Gibco (Carlsbad, CA). Penicillin, 
streptomycin, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide (MTT), and propidium iodide (PI) were 
purchased from Sigma (St Louis, MO). All other reagents 
were commercially available and of analytical grade. Rat 
glioma (C6) cells and mouse fibroblasts (L929) cells were 
provided by the Institute of Biochemistry and Cell Biology 
(Shanghai Institute of Biological Science, Chinese Academy 
of Sciences, China).
Preparation of realgar nanoparticles
Realgar powder was crushed in a mortar, added to 20 mL of 
2 M HCl, and magnetically stirred at 40°C for 3 hours. The 
mixture was washed with distilled water several times until 
the suspension reached a neutral pH, and purified realgar 
was obtained after filtration. Purified realgar was added to 
a saturated Na2S solution, at a molar ratio of 1.4:1, with 
magnetic stirring at a warm temperature. After reaction for 
2 hours under nitrogen protection, and filtered with distilled 
water several times, 0.2 M HCl was slowly added to the dis-
solved compound with constant stirring. The freshly prepared 
aqueous suspension was stored at 4°C in the dark.
characterization of realgar nanoparticles
Transmission electron microscopy (TeM)
All observations were made using a transmission electron 
microscope (H7650; Hitachi High-Technologies Pte Ltd, 
Singapore).
Dynamic light scattering (DLs) analysis
The average size of realgar nanoparticles was measured by 
DLS at a wavelength of 633.0 nm with a detection angle of 
90° using a Brookhaven BI9000AT system (Brookhaven 
Instruments Corp, Holtsville, NY) at 25°C.
energy dispersive spectrometry (eDs)
The elemental composition of realgar nanoparticles and the 
proportions of each element were detected by an energy 
  dispersive spectrometer (Thermo NORAN, Middleton, WI).
Inhibitory effects of realgar nanoparticles 
on c6 cells
MTT assay to measure cell viability  
and proliferation
Both C6 cells and L929 cells were seeded in 96-well plates 
at a density of 1 × 104 cells per well in 200 mL of high-
glucose DMEM supplemented with 10% fetal bovine serum, 
and cultured at 37°C in an incubator with an atmosphere of 
5% CO2. After 24 hours, the cells were treated with realgar 
nanoparticles, purified realgar, or traditional realgar at dif-
ferent concentrations (10, 20, 40, or 80 µg/mL) in triplicate. 
The cells were incubated for another 24, 48, or 72 hours. 
Untreated cells were used as controls, and wells with culture 
medium without cells were used as blank controls. For the 
cell proliferation assay, 100 µL of MTT (5 mg/mL in PBS) 
was added to each well and incubated at 37°C for 4 hours. The 
culture medium was removed, and 200 µL of dimethyl sul-
foxide was added to each well for 5 minutes. The absorbance 
was measured at 570 nm using a universal microplate reader 
(Model EL x800G; BioTek Instruments, Winooski, VT). The 
half maximal inhibitory concentration (IC50) was calculated 
using SPSS software (v 18.0; SPSS Inc, Chicago, IL). Each 
experiment was performed at least three times. For both C6 
and L929 cells, the percentage of cell survival according to 
the concentration of realgar was calculated using the fol-
lowing equation:5 percentage (%) cell survival = [(At − Ab)/
(Ac − Ab)] × 100, where At is the mean absorbance of the test 
well, Ab is the mean absorbance of the blank control, and Ac 
is the mean absorbance of the negative control.
Flow cytometric cell cycle analysis
To evaluate the presence of DNA fragments, cells were 
incubated with realgar nanoparticles, purified realgar, or 
traditional realgar at their respective IC50 values for 24 hours, 
harvested by trypsinization, flushed with complete culture 
medium, washed with PBS, and gently resuspended in 
250 µL of hypotonic fluorochrome solution (50 µg of PI, 
0.1% sodium citrate, and 0.1% Triton X-100 in PBS) with 
100 U/mL RNase A to stain cell nuclei. The DNA content was 
determined by flow cytometry (FACSCalibur; Becton Dick-
inson, Mountain View, CA) and analyzed with   CellQuest 
(Becton Dickenson) and ModFit LT (Verity Software International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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House, Topsham, ME) software. For each sample, a total of 
20,000 events were collected, and cell cycle distribution was 
determined based on DNA content.
Flow cytometric analysis of apoptosis
After treatment of C6 cells with realgar nanoparticles, purified 
realgar, or traditional realgar at their respective IC50 values for 
24 hours, the cells were collected by centrifugation at 1500 
rpm for 3 minutes, washed three times with cold PBS (0.15 M, 
pH 7.2), resuspended in 100 mL of binding buffer, and stained 
with 5 mL of Annexin V-FITC solution together with 5 mL of 
PI solution for 20 minutes at room temperature in the dark. To 
each sample tube, 400 µL of 1× binding buffer was added, and 
the samples were analyzed using a FACSCalibur and CellQuest 
software. All experiments were performed in triplicate.
Immunofluorescence staining
C6 cells were grown on coverslips in 24-well plates, serum-
starved overnight, and treated with realgar nanoparticles, puri-
fied realgar, or traditional realgar at their respective IC50 values 
for 24 hours. The cells were fixed with 4% paraformaldehyde in 
PBS for 15 minutes, blocked with 1% bovine serum albumin in 
PBS for 1 hours, and incubated with specific primary antibody 
(anti-Bcl-2 or anti-Bax diluted 1:200 or 1:100, respectively, in 
blocking buffer) at 4°C overnight. The cells were then incubated 
with secondary antibody (AlexaFluor 532-conjugated anti-
rabbit IgG, diluted 1:200 in blocking buffer) for 1 hour at room 
temperature. Nuclei were counterstained with 4′,6-diamidino-
2-phenylindole (0.5 mg/mL; DAPI) for 10 minutes. Images of 
DAPI and AlexaFluor 532 fluorescence were obtained using 
a fluorescence microscope (IX 71; Olympus, Tokyo, Japan) 
with a ×40 objective lens. Three independent experiments were 
performed with triplicate sample wells.
statistical analysis
All experiments were repeated at least three times, and data for 
each sample were compiled from a minimum of triplicate wells. 
Data are expressed as means ± standard error. The results from 
treated and control cells were analyzed by ANOVA. Values of 
P , 0.05 were taken to indicate statistical significance.
Results and discussion
characterization of realgar nanoparticles
The morphological structure of the realgar nanoparticles was 
analyzed by TEM (Figure 1). The nanoparticles appeared 
round or elliptical in shape, with a mean   diameter of 
0.2 µm
Figure 1 Transmission electron micrograph of realgar nanoparticles.
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Figure 2 hydrodynamic diameter distribution of realgar nanoparticles.
  approximately 60–70 nm. No obvious particle aggregation 
was observed. DLS analyses revealed that the hydrodynamic 
diameter of realgar nanoparticles in water was approximately 
80 nm (Figure 2). Based on EDS (Figure 3 and Table 1), 
the realgar nanoparticle   contained silicon (Si), arsenic (As), 
and sulfur (S). Arsenic and sulfur were present at mass 
  percentages of 26.40% and 11.26%, respectively, and atomic 
percentages 25.68% and 26.12%, respectively, indicating that 
the atomic ratio was   approximately 1:1.
Inhibitory effects of realgar on c6 cells
cell viability and proliferation
MTT assays demonstrated that realgar nanoparticles, puri-
fied realgar, and traditional realgar inhibited the growth of 
C6 cells in a dose- and time-dependent manner (Figure 4). International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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These findings are consistent with those of previous studies 
showing that realgar significantly suppressed the proliferation 
of tumor cells, including HaCaT, SiHa, and NB4-R1 cells, in 
a dose-dependent manner.6–8 Realgar nanoparticles showed 
the greatest anti-proliferative effect, followed by purified 
realgar and then traditional realgar (P , 0.05 for each). 
The IC50 values of realgar nanoparticles were 13 µg/mL 
at 24 hours and 3.2 µg/mL at 48 hours; no cells survived 
after realgar nanoparticle treatment for 72 hours. The IC50 
values of purified realgar were 29.32 µg/mL at 24 hours, 
22.25 µg/mL at 48 hours, and 5.88 µg/mL at 72 hours, and 
those of traditional realgar were 36.56 µg/mL at 24 hours, 
31.79 µg/mL at 48 hours, and 15.41 µg/mL at 72 hours. We 
chose to use 13 µg/mL, the IC50 of realgar nanoparticles 
at 24 hours, for treatments in subsequent experiments. 
The effects of realgar nanoparticles, purified realgar, and 
traditional realgar on the growth of L929 cells showed no 
difference (data not shown).
cell cycle analysis
The cell cycle distribution of C6 cells treated with realgar 
nanoparticles, purified realgar, traditional realgar, or PBS for 
24 hours was analyzed by comparing the percentages of cells 
in G0/G1, S, and G2/M phases, without considering apoptotic 
cells (ie, cells in sub-G0/G1 phase). As shown in Figure 5, 
after treatment with realgar nanoparticles, purified realgar, 
traditional realgar, or PBS for 24 hours, the percentage of 
cells in G1 was significantly decreased, and the percentages 
in G2/M and S phases were increased. These results indicate 
that realgar promoted the arrest of cells in the G2/M phase 
of the cell cycle, thereby inhibiting C6 cell proliferation. 
Similar findings have been reported in human ovarian and 
cervical cancer cells.9
Apoptosis analysis
The anti-apoptotic effect of realgar nanoparticles on C6 cells 
was greater than that of purified or traditional realgar 
(P , 0.05; Figure 6). Purified realgar had a greater anti-
apoptotic effect than traditional realgar (P , 0.05), which 
had a greater effect than control treatment (P , 0.05). The 
percentages of apoptotic cells after treatment with realgar 
nanoparticles, purified realgar, traditional realgar, and control 
were 26.02% ± 0.28%, 6.83% ± 0.39%, 4.73% ± 0.46%, and 
0.91% ± 0.30%, respectively.
Immunofluorescence staining
The apoptosis-related proteins Bcl-2 and Bax play cru-
cial roles in apoptotic progression.10 We determined the 
expression of Bcl-2 and Bax in realgar-treated C6 cells. 
Compared with the Bcl-2 immunofluorescence intensity 
Table  1  elemental  composition  of  realgar  nanoparticles 
determined by energy dispersive spectrometric analysis
Element Wt% At %
si K 62.34 48.20
s K 26.40 26.12
As L 11.26 25.68
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Figure 4 Cytotoxicity of realgar nanoparticles, purified realgar and traditional realgar at 24 hours (A), 48 hours (B), 72 hours (C) in c6 cells.
Note: each data point shown is the mean ± sD from three independent experiments.
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Figure 5 Realgar treatment altered the cell cycle distribution. C6 cells treated with realgar nanoparticles, purified realgar, traditional realgar, or PBS for 24 h were stained 
with PI and analyzed by flow cytometry (A). graphical representation of realgar-treated cells in different phases of cellular cycle. realgar treatment decreased the percentage 
of cells in g0/g1 and increased the percentages of cells in g2/M and s phases (B).
Notes: results represent means ± sD of three independent experiments.
in PBS-treated control cells, Bcl-2 immunofluorescence 
intensity was significantly reduced in realgar-treated cells 
(P , 0.05 for each; Figure 7). The greatest decrease was 
observed in cells treated with realgar nanoparticles, with 
smaller decreases in cells treated with purified realgar or 
traditional realgar. Bcl-2-positive cell frequencies after 
treatment with traditional realgar, purified realgar, and 
realgar nanoparticles were 30% ± 2.52%, 14% ± 2%, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 6 Realgar treatment promoted apoptosis. C6 cells were treated with realgar nanoparticles, purified realgar, traditional realgar, or PBS for 24 hours, stained with 
Annexin V-FITC/PI, and analyzed by flow cytometry (A). realgar treatment increased the percentage of apoptotic cells (B).
Note: results represent means ± sD of three independent experiments.
and 6% ± 4.16%, respectively (Figure 7E). These results 
indicate that realgar induced the downregulated expression 
of the anti-apoptotic Bcl-2 protein in C6 cells. In contrast, 
the expression of the pro-apoptotic Bax protein was upregu-
lated by realgar treatment. Bax-positive cell frequencies 
after treatment with traditional realgar, purified realgar, and 
realgar nanoparticles were 9.3% ± 1.53%, 17% ± 4.5%, and 
42.7% ± 8.33%, respectively (Figure 7E). These findings 
suggest that realgar nanoparticles can trigger apoptosis 
in C6 cells.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 7 Immunofluorescence staining of Bcl-2 and Bax proteins in C6 cells treated with PBS (A), traditional realgar (B), purified realgar (C), or realgar nanoparticles (D). 
Semi-quantitative determination of the percentage of Bcl-2-positive or Bax-positive cells (E).
Notes: Magnification, ×400. experiments were repeated in triplicate. For each sample, the percentage of positive cells was determined by counting four representative areas 
under the fluorescence microscope.
Conclusions
In this study, we successfully developed a new method 
for preparing realgar nanoparticles and showed that they 
significantly inhibited the growth of C6 glioma cells and 
led to cell apoptosis. Furthermore, we demonstrated realgar 
nanoparticles promoted apoptosis by inducing the upregu-
lation of Bax and downregulation of Bcl-2 expression. Our 
study suggests that realgar nanoparticles are a promising in 
vitro anti-cancer strategy and may be applicable for human 
cancer therapy studies and clinical trials.
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